Selected research
Industry Research
Oral Thin Film Drugs Industry Research Report 2026
Market perspective
The global Oral Thin Film Drugs market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Oral Thin Film Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Oral Thin Film Drugs is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Oral Thin Film Drugs is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Oral Thin Film Drugs include Novartis AG, Pfizer, ZIM Laboratories Limited, Wolters Kluwer, Sumitomo Dainippon Pharma Co., Ltd., NAL Pharma, IntelGenx Corp, Indivior Plc. and Allergan Plc., among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Oral Thin Film Drugs market in terms of revenue (US$ million) and, where applicable, sales volume (K Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Oral Thin Film Drugs Market by Company
Novartis AG
Pfizer
ZIM Laboratories Limited
Wolters Kluwer
Sumitomo Dainippon Pharma Co., Ltd.
NAL Pharma
IntelGenx Corp
Indivior Plc.
Allergan Plc.
Oral Thin Film Drugs Segment by Type
Sublingual Film
Fully Dissolving Dental/Buccal Film
Oral Thin Film Drugs Segment by Application
Opioid Dependence
Nausea & Vomiting
Schizophrenia
Migraine
Others
Oral Thin Film Drugs Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Oral Thin Film Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Oral Thin Film Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Oral Thin Film Drugs.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Oral Thin Film Drugs manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Oral Thin Film Drugs by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Oral Thin Film Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Sublingual Film
- Fully Dissolving Dental/Buccal Film
Applications
- Opioid Dependence
- Nausea & Vomiting
- Schizophrenia
- Migraine
- Others
Companies covered
- Novartis AG
- Pfizer
- ZIM Laboratories Limited
- Wolters Kluwer
- Sumitomo Dainippon Pharma Co., Ltd.
- NAL Pharma
- IntelGenx Corp
- Indivior Plc.
- Allergan Plc.
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Oral Thin Film Drugs Market Size (2021-2032)
- 2.2.2 Global Oral Thin Film Drugs Sales (2021-2032)
- 2.2.3 Global Oral Thin Film Drugs Market Average Price (2021-2032)
- 2.3 Oral Thin Film Drugs by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Sublingual Film
- 2.3.3 Fully Dissolving Dental/Buccal Film
- 2.4 Oral Thin Film Drugs by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Opioid Dependence
- 2.4.3 Nausea & Vomiting
- 2.4.4 Schizophrenia
- 2.4.5 Migraine
- 2.4.6 Others
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Oral Thin Film Drugs Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Oral Thin Film Drugs Sales (K Units) of Manufacturers (2021-2026)
- 3.3 Global Oral Thin Film Drugs Revenue of Manufacturers (2021-2026)
- 3.4 Global Oral Thin Film Drugs Average Price by Manufacturers (2021-2026)
- 3.5 Global Oral Thin Film Drugs Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Oral Thin Film Drugs, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Oral Thin Film Drugs, Product Type & Application
- 3.8 Global Manufacturers of Oral Thin Film Drugs, Established Date
- 3.9 Global Oral Thin Film Drugs Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Novartis AG
- 4.1.1 Novartis AG Company Information
- 4.1.2 Novartis AG Business Overview
- 4.1.3 Novartis AG Oral Thin Film Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Novartis AG Oral Thin Film Drugs Product Portfolio
- 4.1.5 Novartis AG Recent Developments
- 4.2 Pfizer
- 4.2.1 Pfizer Company Information
- 4.2.2 Pfizer Business Overview
- 4.2.3 Pfizer Oral Thin Film Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Pfizer Oral Thin Film Drugs Product Portfolio
- 4.2.5 Pfizer Recent Developments
- 4.3 ZIM Laboratories Limited
- 4.3.1 ZIM Laboratories Limited Company Information
- 4.3.2 ZIM Laboratories Limited Business Overview
- 4.3.3 ZIM Laboratories Limited Oral Thin Film Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 ZIM Laboratories Limited Oral Thin Film Drugs Product Portfolio
- 4.3.5 ZIM Laboratories Limited Recent Developments
- 4.4 Wolters Kluwer
- 4.4.1 Wolters Kluwer Company Information
- 4.4.2 Wolters Kluwer Business Overview
- 4.4.3 Wolters Kluwer Oral Thin Film Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Wolters Kluwer Oral Thin Film Drugs Product Portfolio
- 4.4.5 Wolters Kluwer Recent Developments
- 4.5 Sumitomo Dainippon Pharma Co., Ltd.
- 4.5.1 Sumitomo Dainippon Pharma Co., Ltd. Company Information
- 4.5.2 Sumitomo Dainippon Pharma Co., Ltd. Business Overview
- 4.5.3 Sumitomo Dainippon Pharma Co., Ltd. Oral Thin Film Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Sumitomo Dainippon Pharma Co., Ltd. Oral Thin Film Drugs Product Portfolio
- 4.5.5 Sumitomo Dainippon Pharma Co., Ltd. Recent Developments
- 4.6 NAL Pharma
- 4.6.1 NAL Pharma Company Information
- 4.6.2 NAL Pharma Business Overview
- 4.6.3 NAL Pharma Oral Thin Film Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 NAL Pharma Oral Thin Film Drugs Product Portfolio
- 4.6.5 NAL Pharma Recent Developments
- 4.7 IntelGenx Corp
- 4.7.1 IntelGenx Corp Company Information
- 4.7.2 IntelGenx Corp Business Overview
- 4.7.3 IntelGenx Corp Oral Thin Film Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 IntelGenx Corp Oral Thin Film Drugs Product Portfolio
- 4.7.5 IntelGenx Corp Recent Developments
- 4.8 Indivior Plc.
- 4.8.1 Indivior Plc. Company Information
- 4.8.2 Indivior Plc. Business Overview
- 4.8.3 Indivior Plc. Oral Thin Film Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Indivior Plc. Oral Thin Film Drugs Product Portfolio
- 4.8.5 Indivior Plc. Recent Developments
- 4.9 Allergan Plc.
- 4.9.1 Allergan Plc. Company Information
- 4.9.2 Allergan Plc. Business Overview
- 4.9.3 Allergan Plc. Oral Thin Film Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Allergan Plc. Oral Thin Film Drugs Product Portfolio
- 4.9.5 Allergan Plc. Recent Developments
5 Global Oral Thin Film Drugs Market Scenario by Region
- 5.1 Global Oral Thin Film Drugs Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Oral Thin Film Drugs Sales by Region: 2021-2032
- 5.2.1 Global Oral Thin Film Drugs Sales by Region: 2021-2026
- 5.2.2 Global Oral Thin Film Drugs Sales by Region: 2027-2032
- 5.3 Global Oral Thin Film Drugs Revenue by Region: 2021-2032
- 5.3.1 Global Oral Thin Film Drugs Revenue by Region: 2021-2026
- 5.3.2 Global Oral Thin Film Drugs Revenue by Region: 2027-2032
- 5.4 North America Oral Thin Film Drugs Market Facts & Figures by Country
- 5.4.1 North America Oral Thin Film Drugs Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Oral Thin Film Drugs Sales by Country (2021-2032)
- 5.4.3 North America Oral Thin Film Drugs Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.5 Europe Oral Thin Film Drugs Market Facts & Figures by Country
- 5.5.1 Europe Oral Thin Film Drugs Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Oral Thin Film Drugs Sales by Country (2021-2032)
- 5.5.3 Europe Oral Thin Film Drugs Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Netherlands
- 5.6 Asia Pacific Oral Thin Film Drugs Market Facts & Figures by Country
- 5.6.1 Asia Pacific Oral Thin Film Drugs Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Oral Thin Film Drugs Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Oral Thin Film Drugs Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 China Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Oral Thin Film Drugs Market Facts & Figures by Country
- 5.7.1 South America Oral Thin Film Drugs Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Oral Thin Film Drugs Sales by Country (2021-2032)
- 5.7.3 South America Oral Thin Film Drugs Revenue by Country (2021-2032)
- 5.7.4 Mexico
- 5.7.5 Brazil
- 5.7.6 Argentina
- 5.8 Middle East and Africa Oral Thin Film Drugs Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Oral Thin Film Drugs Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Oral Thin Film Drugs Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Oral Thin Film Drugs Revenue by Country (2021-2032)
- 5.8.4 Turkey
- 5.8.5 Saudi Arabia
- 5.8.6 UAE
6 Segment by Type
- 6.1 Global Oral Thin Film Drugs Sales by Type (2021-2032)
- 6.1.1 Global Oral Thin Film Drugs Sales by Type (2021-2032) & (K Units)
- 6.1.2 Global Oral Thin Film Drugs Sales Market Share by Type (2021-2032)
- 6.2 Global Oral Thin Film Drugs Revenue by Type (2021-2032)
- 6.2.1 Global Oral Thin Film Drugs Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Oral Thin Film Drugs Revenue Market Share by Type (2021-2032)
- 6.3 Global Oral Thin Film Drugs Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Oral Thin Film Drugs Sales by Application (2021-2032)
- 7.1.1 Global Oral Thin Film Drugs Sales by Application (2021-2032) & (K Units)
- 7.1.2 Global Oral Thin Film Drugs Sales Market Share by Application (2021-2032)
- 7.2 Global Oral Thin Film Drugs Revenue by Application (2021-2032)
- 7.2.1 Global Oral Thin Film Drugs Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Oral Thin Film Drugs Revenue Market Share by Application (2021-2032)
- 7.3 Global Oral Thin Film Drugs Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Oral Thin Film Drugs Value Chain Analysis
- 8.1.1 Oral Thin Film Drugs Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Oral Thin Film Drugs Production Mode & Process
- 8.2 Oral Thin Film Drugs Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Oral Thin Film Drugs Distributors
- 8.2.3 Oral Thin Film Drugs Customers
9 Global Oral Thin Film Drugs Analyzing Market Dynamics
- 9.1 Oral Thin Film Drugs Industry Trends
- 9.2 Oral Thin Film Drugs Industry Drivers
- 9.3 Oral Thin Film Drugs Industry Opportunities and Challenges
- 9.4 Oral Thin Film Drugs Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst